You've just added:

Home / News

News + Media

April 28, 2022

Harrington Discovery Institute Announces 2022 Grant Funding to 11 Physician-Scientists

More than 150 drug discovery projects now supported by Harrington Discovery Institute Continue Reading

April 25, 2022

Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics

Novel CryptigenTM technology unlocks full potential of Tumour Specific Antigens Continue Reading

March 24, 2022

International Harrington Prize Jointly Awarded to Drs. James Crowe and Michel Nussenzweig

2022 Harrington Prize for Innovation in Medicine Recognizes Breakthrough Innovations in the Use of Human Antibodies to Treat COVID-19March 24, 2022, Cleveland, Ohio – The ninth annual Harrington Prize for Innovation in Medicine has been jointly awarded to James E. Crowe, Jr., MD, Director, Vanderbilt Vaccine Center and... Continue Reading

February 23, 2022

Harrington Discovery Institute Opens Call for 2023 Harrington Scholar-Innovator Award

February 23, 2022, CLEVELAND, Ohio USA - Harrington Discovery Institute at University Hospitals is now accepting the Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical... Continue Reading

February 05, 2022

Chiesi Enters Agreement with Allinaire Therapeutic, LLC

Chiesi Acquires Pioneering Therapeutic Monoclonal Antibodies Portfolio Against EMAP II as Potential Treatment for PAH Continue Reading

January 24, 2022

Linda and Les Vinney Scholar Program to Support New Treatments for Alzheimer’s Disease

Linda and Les Vinney committed $1.25 million to establish the Linda and Les Vinney Scholar Program at Harrington Discovery Institute's Center for Brain Health Medicine, which will support new treatments for patients living with Alzheimer's disease. The gift also creates the Linda and Les Vinney Acceleration Awards, which will... Continue Reading

January 18, 2022

Harrington Discovery Institute Advances COVID-19 Treatments

Four Medicines in Clinical Trials and More in the Pipeline Continue Reading

December 09, 2021

LSU And Takeda Partner To Advance Harrington Scholar’s Therapy For Rare Neurological Disorders

New Orleans, LA – LSU Health New Orleans entered into an exclusive option and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) granting Takeda the exclusive right to develop further a technology invented at LSU Health New Orleans with the aim to discover potential therapeutics to treat rare... Continue Reading